Chiba University
Chiba, 260-8677, Japan
NCT Number: NCT01256047
The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with major hepatectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Chiba, 260-8677, Japan
The investigators reported that preoperative immunonutrition improve the incidence of postoperative infectious complication in patients after hepatectomy, and modulation of Th1/Th2 differentiation may play important roles in this effect.
Object of this study is to investigate the effects of preoperative immunonutrition on incidence of postoperative infectious complication, and Th1/Th2 balance after hepatectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral supplement for 5 days(1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA
Other names: Oral IMPACT; Ajinomoto Pharma Co., Ltd, Tokyo, Japan
Time frame: 30 days
Time frame: 14 days
Chiba University
Other
Effects of Preoperative Immunonutrition on Infectious Complication and Th1/Th2 Differentiation in Patients Undergoing Hepatectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763642
Ampulla of Vater Cancer, Bile Duct Cancer
Krasnodar, Krasnodarskiy Kray, Russia
View Trial DetailsNCT04853017
Adenocarcinoma, Adnexal Diseases
Duarte, California, United States
View Trial DetailsNCT02375880
Adenocarcinoma, Bile Duct Cancer
Los Angeles, California, United States
View Trial DetailsNCT03058289
Bile Duct Cancer, Bile Duct Diseases
Los Angeles, California, United States
View Trial Details